نمایش پرونده ساده آیتم

dc.contributor.authorRaoufinia, R
dc.contributor.authorMota, A
dc.contributor.authorNozari, S
dc.contributor.authorAghebati Maleki, L
dc.contributor.authorBalkani, S
dc.contributor.authorAbdolalizadeh, J
dc.date.accessioned2018-08-26T08:32:22Z
dc.date.available2018-08-26T08:32:22Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52283
dc.description.abstractAs the most predominant protein in plasma, albumin is synthesized in the liver. Given to various applications of albumin as biopharmaceutical agent, the annual demand for it is 500 tons in the world, which is the highest in the biomedical solutions demand ranking. There exist different procedures for production of albumin. The aim of this study was the purification of human serum albumin (HSA) using immunoaffinity chromatography. After immunization of rabbits, passive immunodiffusion and indirect ELISA tests were applied for assessment of polyclonal antibody production against HSA. Purification was performed by ion exchange chromatography (IEC) and protein G affinity chromatography. The produced anti-HSA IgG was attached to the CNBR-activated Sepharose and applied for albumin purification from human serum. Western blotting (WB) analysis and heat-induced insolubility were performed for functional and stability measurement assessment of immunoaffinity purified HSA, respectively. The optimum titer of anti-HSA determined by indirect ELISA was 256000. The SDS-PAGE showed that the purity rate of albumin was approximately 98% and WB confirmed the HSA functionality. Also, the heat-induced insolubility of immunoaffinity purified HSA was the same as the commercial HSA. Affinity chromatography using produced polyclonal antibody would be a robust method for purification of HSA. é 2016 Taylor & Francis.
dc.language.isoEnglish
dc.relation.ispartofJournal of Immunoassay and Immunochemistry
dc.subjectalbumin antibody
dc.subjectcyanogen bromide
dc.subjectimmunoglobulin G antibody
dc.subjectpolyclonal antibody
dc.subjectprotein G
dc.subjectrecombinant human serum albumin
dc.subjectsepharose
dc.subjectimmunoglobulin G
dc.subjectserum albumin
dc.subjectaffinity chromatography
dc.subjectanalytic method
dc.subjectanimal experiment
dc.subjectantibody production
dc.subjectantibody titer
dc.subjectArticle
dc.subjectbioseparation
dc.subjectcontrolled study
dc.subjectdrug purification
dc.subjectdrug stability
dc.subjectenzyme linked immunosorbent assay
dc.subjectgel
dc.subjectheat
dc.subjecthuman
dc.subjectimmunization
dc.subjectimmunoaffinity chromatography
dc.subjectimmunodiffusion
dc.subjection exchange chromatography
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectprotein function
dc.subjectrabbit
dc.subjectserum
dc.subjectsolubility
dc.subjectWestern blotting
dc.subjectanimal
dc.subjectantigen antibody reaction
dc.subjectenzyme linked immunosorbent assay
dc.subjectimmunology
dc.subjection exchange chromatography
dc.subjectisolation and purification
dc.subjectpolyacrylamide gel electrophoresis
dc.subjectrabbits and hares
dc.subjectAnimals
dc.subjectAntigen-Antibody Reactions
dc.subjectChromatography, Affinity
dc.subjectChromatography, Ion Exchange
dc.subjectElectrophoresis, Polyacrylamide Gel
dc.subjectEnzyme-Linked Immunosorbent Assay
dc.subjectHumans
dc.subjectImmunoglobulin G
dc.subjectRabbits
dc.subjectSerum Albumin
dc.titleA methodological approach for purification and characterization of human serum albumin
dc.typeArticle
dc.citation.volume37
dc.citation.issue6
dc.citation.spage623
dc.citation.epage635
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1080/15321819.2016.1184163


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم